STAAR Total Liab vs Deferred Long Term Liab Analysis

STAA Stock

USD 29.10 0.92 3.26%

STAAR Surgical financial indicator trend analysis is much more than just breaking down STAAR Surgical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether STAAR Surgical is a good investment. Please check the relationship between STAAR Surgical Total Liab and its Deferred Long Term Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.

Total Liab vs Deferred Long Term Liab

Total Liab vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of STAAR Surgical Total Liab account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between STAAR Surgical's Total Liab and Deferred Long Term Liab is -0.69. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of STAAR Surgical, assuming nothing else is changed. The correlation between historical values of STAAR Surgical's Total Liab and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of STAAR Surgical are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Total Liab i.e., STAAR Surgical's Total Liab and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.69

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from STAAR Surgical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into STAAR Surgical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.At present, STAAR Surgical's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 13 M, whereas Issuance Of Capital Stock is forecasted to decline to 855.00.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	145.3M	179.6M	224.6M	235.8M
Cost Of Revenue	51.8M	61.0M	69.8M	73.3M

Total Operating Expenses Cost Of Revenue

STAAR Surgical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Intangible Assets	Common Stock Total Equity
Total Assets		0.94	0.98	0.99	1.0	0.98	-0.83	0.51	0.89	0.98	0.0	0.98	0.97	0.39	0.94	0.91	0.93	0.94	0.99	0.96	1.0	0.38	0.81	0.3	-0.56	0.39
Short Long Term Debt Total	0.94		0.92	0.91	0.93	0.98	-0.7	0.67	0.79	0.97	0.18	0.9	0.91	0.19	0.98	0.81	0.82	0.81	0.96	0.95	0.92	0.23	0.78	0.11	-0.48	0.21
Other Current Liab	0.98	0.92		0.96	0.97	0.94	-0.85	0.49	0.9	0.93	0.0	0.99	0.9	0.4	0.94	0.81	0.93	0.92	0.98	0.89	0.98	0.35	0.69	0.27	-0.56	0.39
Total Current Liabilities	0.99	0.91	0.96		0.99	0.97	-0.85	0.43	0.91	0.96	-0.07	0.97	0.97	0.44	0.91	0.92	0.95	0.96	0.99	0.95	0.99	0.47	0.82	0.38	-0.57	0.45
Total Stockholder Equity	1.0	0.93	0.97	0.99		0.98	-0.82	0.5	0.89	0.97	-0.01	0.98	0.97	0.39	0.93	0.91	0.92	0.95	0.99	0.95	1.0	0.38	0.81	0.31	-0.56	0.4
Property Plant And Equipment Net	0.98	0.98	0.94	0.97	0.98		-0.74	0.59	0.82	1.0	0.07	0.93	0.97	0.3	0.96	0.91	0.89	0.89	0.98	0.99	0.96	0.31	0.84	0.24	-0.52	0.31
Net Debt	-0.83	-0.7	-0.85	-0.85	-0.82	-0.74		-0.22	-0.99	-0.71	0.11	-0.89	-0.74	-0.49	-0.78	-0.68	-0.88	-0.86	-0.84	-0.71	-0.86	-0.61	-0.51	-0.35	0.54	-0.47
Retained Earnings	0.51	0.67	0.49	0.43	0.5	0.59	-0.22		0.32	0.62	0.8	0.45	0.53	-0.51	0.66	0.39	0.27	0.2	0.54	0.61	0.47	-0.28	0.29	-0.6	-0.15	-0.46
Cash	0.89	0.79	0.9	0.91	0.89	0.82	-0.99	0.32		0.8	-0.06	0.93	0.82	0.44	0.85	0.75	0.91	0.89	0.9	0.8	0.92	0.55	0.59	0.32	-0.56	0.43
Non Current Assets Total	0.98	0.97	0.93	0.96	0.97	1.0	-0.71	0.62	0.8		0.1	0.92	0.97	0.27	0.95	0.91	0.87	0.87	0.97	0.99	0.96	0.28	0.84	0.21	-0.5	0.29
Non Currrent Assets Other	0.0	0.18	0.0	-0.07	-0.01	0.07	0.11	0.8	-0.06	0.1		-0.04	0.05	-0.77	0.2	-0.09	-0.22	-0.3	0.04	0.13	-0.03	-0.41	-0.19	-0.9	0.01	-0.71
Cash And Short Term Investments	0.98	0.9	0.99	0.97	0.98	0.93	-0.89	0.45	0.93	0.92	-0.04		0.9	0.44	0.92	0.83	0.93	0.95	0.97	0.89	0.99	0.42	0.72	0.32	-0.57	0.43
Net Receivables	0.97	0.91	0.9	0.97	0.97	0.97	-0.74	0.53	0.82	0.97	0.05	0.9		0.3	0.88	0.97	0.87	0.9	0.95	0.99	0.95	0.36	0.87	0.28	-0.53	0.34
Common Stock Shares Outstanding	0.39	0.19	0.4	0.44	0.39	0.3	-0.49	-0.51	0.44	0.27	-0.77	0.44	0.3		0.19	0.38	0.55	0.63	0.35	0.23	0.42	0.71	0.42	0.92	-0.28	0.98
Non Current Liabilities Total	0.94	0.98	0.94	0.91	0.93	0.96	-0.78	0.66	0.85	0.95	0.2	0.92	0.88	0.19		0.77	0.86	0.81	0.97	0.92	0.92	0.25	0.69	0.07	-0.52	0.19
Inventory	0.91	0.81	0.81	0.92	0.91	0.91	-0.68	0.39	0.75	0.91	-0.09	0.83	0.97	0.38	0.77		0.85	0.89	0.88	0.94	0.9	0.4	0.9	0.41	-0.51	0.42
Other Current Assets	0.93	0.82	0.93	0.95	0.92	0.89	-0.88	0.27	0.91	0.87	-0.22	0.93	0.87	0.55	0.86	0.85		0.95	0.93	0.85	0.94	0.52	0.71	0.46	-0.65	0.53
Other Stockholder Equity	0.94	0.81	0.92	0.96	0.95	0.89	-0.86	0.2	0.89	0.87	-0.3	0.95	0.9	0.63	0.81	0.89	0.95		0.92	0.85	0.96	0.54	0.81	0.57	-0.59	0.62
Total Liab	0.99	0.96	0.98	0.99	0.99	0.98	-0.84	0.54	0.9	0.97	0.04	0.97	0.95	0.35	0.97	0.88	0.93	0.92		0.96	0.98	0.39	0.79	0.26	-0.56	0.35
Property Plant And Equipment Gross	0.96	0.95	0.89	0.95	0.95	0.99	-0.71	0.61	0.8	0.99	0.13	0.89	0.99	0.23	0.92	0.94	0.85	0.85	0.96		0.94	0.31	0.85	0.2	-0.48	0.26
Total Current Assets	1.0	0.92	0.98	0.99	1.0	0.96	-0.86	0.47	0.92	0.96	-0.03	0.99	0.95	0.42	0.92	0.9	0.94	0.96	0.98	0.94		0.41	0.79	0.33	-0.58	0.42
Short Term Debt	0.38	0.23	0.35	0.47	0.38	0.31	-0.61	-0.28	0.55	0.28	-0.41	0.42	0.36	0.71	0.25	0.4	0.52	0.54	0.39	0.31	0.41		0.36	0.63	-0.32	0.75
Accounts Payable	0.81	0.78	0.69	0.82	0.81	0.84	-0.51	0.29	0.59	0.84	-0.19	0.72	0.87	0.42	0.69	0.9	0.71	0.81	0.79	0.85	0.79	0.36		0.47	-0.47	0.44
Common Stock	0.3	0.11	0.27	0.38	0.31	0.24	-0.35	-0.6	0.32	0.21	-0.9	0.32	0.28	0.92	0.07	0.41	0.46	0.57	0.26	0.2	0.33	0.63	0.47		-0.11	0.92
Intangible Assets	-0.56	-0.48	-0.56	-0.57	-0.56	-0.52	0.54	-0.15	-0.56	-0.5	0.01	-0.57	-0.53	-0.28	-0.52	-0.51	-0.65	-0.59	-0.56	-0.48	-0.58	-0.32	-0.47	-0.11		-0.2
Common Stock Total Equity	0.39	0.21	0.39	0.45	0.4	0.31	-0.47	-0.46	0.43	0.29	-0.71	0.43	0.34	0.98	0.19	0.42	0.53	0.62	0.35	0.26	0.42	0.75	0.44	0.92	-0.2

Click cells to compare fundamentals

STAAR Surgical Account Relationship Matchups

STAAR Surgical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	206.9M	257.4M	345.8M	415.1M	488.7M	513.1M
Short Long Term Debt Total	9.5M	10.8M	32.1M	31.0M	35.8M	37.6M
Other Current Liab	14.2M	25.0M	30.2M	32.6M	31.9M	33.5M
Total Current Liabilities	34.5M	41.2M	48.8M	51.7M	65.0M	68.3M
Total Stockholder Equity	159.9M	197.2M	258.6M	332.4M	386.0M	405.3M
Property Plant And Equipment Net	25.6M	33.4M	67.7M	81.5M	101.4M	106.5M
Net Debt	(110.4M)	(141.7M)	(167.6M)	(55.4M)	(147.2M)	(139.8M)
Retained Earnings	(141.8M)	(135.9M)	(111.4M)	(72.4M)	(47.4M)	(49.7M)
Cash	120.0M	152.5M	199.7M	86.5M	183.0M	192.2M
Non Current Assets Total	32.2M	41.0M	74.4M	103.2M	123.4M	129.6M
Non Currrent Assets Other	751K	608K	822K	957K	3.3M	1.8M
Cash And Short Term Investments	120.0M	152.5M	199.7M	211.6M	220.7M	231.8M
Net Receivables	31.0M	35.2M	43.5M	62.4M	98.0M	102.9M
Common Stock Shares Outstanding	46.9M	48.0M	49.5M	49.4M	49.4M	28.8M
Liabilities And Stockholders Equity	206.9M	257.4M	345.8M	415.1M	488.7M	513.1M
Non Current Liabilities Total	12.5M	19.0M	38.4M	31.0M	37.7M	39.6M
Inventory	17.1M	18.1M	17.3M	24.2M	35.1M	36.9M
Other Current Assets	6.6M	10.6M	10.9M	9.5M	11.4M	12.0M
Other Stockholder Equity	304.3M	338.2M	373.5M	404.2M	436.9M	458.8M
Total Liab	47.0M	60.2M	87.2M	82.7M	102.7M	107.9M
Property Plant And Equipment Gross	25.6M	33.4M	67.7M	81.5M	137.2M	144.0M
Total Current Assets	174.7M	216.4M	271.4M	312.0M	365.3M	383.5M
Accumulated Other Comprehensive Income	(3.0M)	(5.5M)	(4.0M)	156K	(4.1M)	(4.3M)
Short Term Debt	8.3M	7.1M	6.8M	3.7M	8.7M	4.6M
Accounts Payable	8.1M	2.8M	8.7M	11.6M	13.6M	14.2M
Common Stock	448K	464K	477K	482K	488K	271.6K
Intangible Assets	296K	270K	218K	173K	155.7K	147.9K
Common Stock Total Equity	414K	442K	448K	464K	533.6K	313.8K
Other Liab	8.1M	12.4M	9.8M	3.6M	4.2M	3.8M
Current Deferred Revenue	3.6M	4.5M	4.8M	(1.3K)	10.8M	10.3M
Other Assets	4.5M	5.6M	4.6M	5.8M	6.6M	7.0M
Property Plant Equipment	17.1M	24.0M	67.7M	81.5M	93.8M	98.5M
Net Tangible Assets	157.8M	195.2M	256.6M	330.2M	379.8M	398.8M
Retained Earnings Total Equity	(161.2M)	(156.3M)	(141.8M)	(135.9M)	(122.3M)	(128.4M)
Capital Surpluse	204.9M	289.6M	304.3M	338.2M	388.9M	240.9M
Capital Lease Obligations	7.7M	9.4M	32.1M	31.0M	35.8M	37.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:

How To Invest In STAAR

Details

Is STAAR Stock a good investment?

Details

What is STAAR Surgical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.018

Earnings Share

0.44

Revenue Per Share

6.962

Quarterly Revenue Growth

0.103

Return On Assets

0.0339

The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

STAAR Total Liab vs Deferred Long Term Liab Analysis

Total Liab vs Deferred Long Term Liab

Total Liab vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Total Liab

Deferred Long Term Liab

STAAR Surgical fundamental ratios Correlations

STAAR Surgical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

STAAR Surgical fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Liabilities	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Common Stock	- 0.9	Non Currrent Assets Other
Cash And Short Term Investments	- 0.89	Net Debt
Other Current Assets	- 0.88	Net Debt
Total Current Assets	- 0.86	Net Debt
Other Stockholder Equity	- 0.86	Net Debt